Hint mode is switched on Switch off
For swift navigation between sections

Shire US
LEI 5493005GAFWSYBKY6W04

Organization name
Shire US, Inc.
Country name
USA
Country of registration
USA
Industry
Miscellaneous Healthcare: Products and Services
Public debt
1,500 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Shire US, Inc., a pharmaceutical company, develops and markets pharmaceutical products. The company focuses on central nervous system disorders, gastro intestinal, oncology, and anti-infective therapeutic areas. It markets products to specialist doctors. The company was formerly known as Shire Richwood, Inc. The company was founded in 1990 and is based in Lexington, Massachusetts. As of August 22, 1997, Shire US, Inc. operates as a subsidiary of Shire plc.

Awards

Documentation

Stocks

Latest issues

Bond classification

  • Organization does not disclose IFRS/US GAAP financial statements

Public debt by currencies

Codes

  • LEI
    5493005GAFWSYBKY6W04
Registration is required to get access.